Scorpion Capital shorts TransMedics, alleging fraud in report
In This Article:
Shares of TransMedics (TMDX) are falling after Scorpion Capital revealed its short position on the company Friday. The investment firm alleges fraudulent practices at TransMedics, describing it as "the most extreme and grotesque healthcare fraud we have encountered."
Market Domination hosts Julie Hyman and Josh Lipton examine the details behind these allegations.
To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
This post was written by Angel Smith